ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET FORECAST 2021-2028

The Asia-Pacific sepsis diagnostics market growth is projected to progress at a CAGR of 8.57% during the forecast period, 2021-2028. The economic development, the steady evolution of the medical healthcare system, and the demand for sepsis diagnostics, offer lucrative growth opportunities.

asia-pacific-sepsis-diagnostics-market

The Asia-Pacific sepsis diagnostics market growth evaluation includes the analysis of Indonesia, Japan, China, Australia & New Zealand, Vietnam, South Korea, India, Thailand, and Rest of Asia-Pacific. There are growing incidences of sepsis in China, leading to mortality. The lack of epidemiological data has led to high mortality rates. As per the recent clinical criteria study (2014), 484 patients, i.e., 37.3 per 100 ICU admissions, had severe sepsis. The high mortality has resulted in an increasing need to enhance the early sepsis triage system, control nosocomial infections, and strengthen clinicians' core knowledge and skills. Moreover, it has been assessed that the elderly and neonates are at greater risk. Such factors are expected to boost the market growth in China.

In countries like South Korea, sepsis had increased from 173.8 per 100,000 population in 2007 to 23.6 per 100,000 in 2016. The government thus aims to provide professional officials at hospitals. Also, authorities have started a 'sepsis registration project' that will help hospitals employ more medical workers for sepsis care in intensive care units (ICUs). There have been initiatives like field events and annual symposia since 2012, for promoting educational activities for the public. Such factors are estimated to contribute to the market growth.

Danaher Corporation designs and manufactures medical, industrial, commercial, and professional products and services. The operations are centered on developing applications for environmental and applied solutions, medical diagnostics, life sciences, and dental care. The product portfolio includes microsystems for life sciences research and software for medical diagnostics purposes, among others. The company operates across Europe, Asia-Pacific, and the Americas, with its headquarters in Washington DC, the US.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. PREVAILING BURDEN OF SEPSIS
      2. COMPLICATIONS ARISING DUE TO HOSPITAL-ACQUIRED INFECTIONS (HAIS)
      3. SPREAD OF INFECTIOUS DISEASES AUGMENTING SEPSIS PROCEDURES
      4. SURGING GOVERNMENT INITIATIVES
    2. KEY RESTRAINTS
      1. COMPLICATIONS ASSOCIATED WITH THE REIMBURSEMENT POLICIES
      2. HIGH COST OF AN AUTOMATED DIAGNOSTICS INSTRUMENT
  4. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET
    2. KEY INVESTMENT INSIGHTS
    3. PORTER'S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  5. MARKET BY TECHNOLOGY
    1. MICROBIOLOGY
    2. IMMUNOASSAY
    3. MOLECULAR DIAGNOSTICS
    4. OTHER TECHNOLOGIES
  6. MARKET BY DIAGNOSTIC METHOD
    1. CONVENTIONAL DIAGNOSTICS
    2. AUTOMATED DIAGNOSTICS
  7. MARKET BY PRODUCT
    1. BLOOD CULTURE MEDIA
    2. ASSAY KITS & REAGENTS
    3. INSTRUMENTS
  8. MARKET BY PATHOGEN
    1. GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS
    2. FUNGAL SEPSIS
    3. OTHER PATHOGENS
  9. MARKET BY TESTING TYPE
    1. LABORATORY TESTING
    2. POINT-OF-CARE TESTING
  10. GEOGRAPHICAL ANALYSIS
    1. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. CHINA
        2. JAPAN
        3. AUSTRALIA & NEW ZEALAND
        4. INDIA
        5. SOUTH KOREA
        6. THAILAND
        7. INDONESIA
        8. VIETNAM
        9. REST OF ASIA-PACIFIC
  11. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
      4. BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
    2. COMPANY PROFILES
      1. ABBOTT LABORATORIES
      2. BECTON, DICKINSON AND COMPANY
      3. BIOMERIEUX SA
      4. BRUKER CORPORATION
      5. CYTOSORBENTS
      6. DANAHER
      7. EKF DIAGNOSTICS
      8. F. HOFFMANN-LA ROCHE
      9. IMMUNEXPRESS INC
      10. LUMINEX CORPORATION
      11. RESPONSE BIOMEDICAL CORPORATION
      12. T2 BIOSYSTEMS INC
      13. THERMO FISHER SCIENTIFIC INC
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - SEPSIS DIAGNOSTICS

TABLE 2: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GRAM-NEGATIVE BACTERIA CAUSING SEPSIS

TABLE 11: GRAM-POSITIVE BACTERIA CAUSING SEPSIS

TABLE 12: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: LEADING PLAYERS OPERATING IN ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET

TABLE 17: LIST OF MERGERS & ACQUISITIONS

TABLE 18: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS

TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY INVESTMENT INSIGHTS

FIGURE 2: PORTER'S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, IN 2020

FIGURE 6: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 7: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)

FIGURE 8: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 9: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

FIGURE 10: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, IN 2020

FIGURE 11: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 12: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, IN 2020

FIGURE 14: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)

FIGURE 15: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $ MILLION)

FIGURE 16: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 17: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, IN 2020

FIGURE 18: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS, 2021-2028 (IN $ MILLION)

FIGURE 19: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)

FIGURE 20: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)

FIGURE 21: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, IN 2020

FIGURE 22: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 23: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)

FIGURE 24: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 25: GERMANY SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 26: CHINA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: JAPAN SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 28: AUSTRALIA & NEW ZEALAND SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: INDIA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: SOUTH KOREA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: THAILAND SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: INDONESIA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 33: VIETNAM SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: REST OF ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample